We surveyed 1,000+ patients to uncover their perspectives about direct‑to‑patient. Read the report
Resource Hub
Insights to Move Your Access Strategy Forward
A curated library of research, thought leadership, and expert perspectives for pharma manufacturers that want to drive best-in-class results.
Featured Resources
Explore topics
press
Protecting Gross-to-Net Performance Through Single-Channel Ecosystems
Readreport
Building Direct-to-Patient Programs that Exceed Today's Patient Expectations
Downloadpress
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program
Readreport
Bridging the Gap to Better Patient Outcomes: What HCPs Want from Pharma's Digital Access Channels
Downloadwebinar
Capturing Actionable Metrics to Improve Patient & Brand Outcomes
Watchpress
The Hidden GTN Drain: Why Specialty-Lite Brands Need To Streamline The PA Process
Readpress
Sprout Pharmaceuticals and PHIL Expand Their Affordable Direct-to-Patient Access Program for Addyi
Readpress
Redefining Commercial Success in Speciaty-Lite
Readpress
Pharma Direct-To-Patient 2.0: From Experiment To Imperative
ReadShowing 1–9 of 102 resources
In the news
PHIL in the press
Recent thought leadership in renowned industry publications and outlets.
Drug Channels
Beyond DTP 2.0: How Flexible FTP Programs Power Superior Patient Experiences
Read featureFierce Pharma
The Hidden GTN Drain: Why Streamlining the PA Process is Key to Commercial Success
Read featureLife Science Leader
Pharma Direct-To-Patient 2.0: From Experiment to Imperative
Read featureBioPharma Dive
Bridging Data Gaps that Impact Retail and Specialty-lite Success
Read featureReady to simplify medication access?
See how PHIL moves more patients to therapy, quickly and affordably
Take a tour of the PHIL platform and discover how we can help amplify starts, adherence, coverage, and commercial success.
Corporate Headquarters
14500 N Northsight Blvd, Suite 307, Scottsdale, AZ 85260
